Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death

Area of Science:

• Immunology
• Oncology
• Infectious Diseases

Background:

• Cancer prevalence and mortality are rising, particularly in patients experiencing infections.
• The impact of infections on anti-tumor immune responses remains incompletely understood.

Purpose of the Study:

• To investigate how acute infections influence anti-tumor immunity and cancer progression.
• To explore the potential of immunotherapy in managing infection-induced tumor growth.

Main Methods:

• Utilizing a murine model, researchers induced acute influenza infection in mice with distal melanoma.
• Flow cytometry and immunohistochemistry were employed to analyze CD8+ T cell migration and programmed cell death protein 1 (PD-1) expression.
• Therapeutic intervention using PD-1 blockade was assessed for its efficacy in reversing infection-induced immune changes and tumor growth.

Main Results:

• Acute influenza infection accelerated melanoma growth in the dermis and increased cancer-specific mortality.
• Anti-melanoma CD8+ T cells were observed to migrate from tumors to the infection site during influenza, expressing high levels of PD-1.
• PD-1 blockade therapy successfully redirected CD8+ T cells back to the tumor and inhibited infection-exacerbated tumor growth.

Conclusions:

• Acute, non-oncogenic infections can promote cancer progression by impairing anti-tumor immune surveillance.
• Targeting the PD-1 pathway presents a promising therapeutic strategy for enhancing anti-tumor immunity during concurrent viral infections.
• Understanding immune responses to combined challenges is crucial for optimizing cancer immunotherapy and managing patients with co-existing conditions.